Genmab Share Price Nasdaq Copenhagen
Stocks
DK0010272202
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,888.75 DKK | +55.20% |
|
+4.14% | +14.24% |
| 10:28am | Nordic stocks in North America - AstraZeneca rose 2.5 percent | FW |
| 30/07 | Nordic stocks in North America, Ericsson fell 1.7% | FW |
| Market Cap | 11TCr 1.74TCr 1.52TCr 1.42TCr 1.3TCr 2.45TCr 1,66200Cr 2.49TCr 17TCr 6.54TCr 83TCr 6.55TCr 6.41TCr 2,73400Cr | P/E 2026 * |
24.1x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 13TCr 2.04TCr 1.78TCr 1.66TCr 1.52TCr 2.87TCr 1,94700Cr 2.92TCr 20TCr 7.65TCr 97TCr 7.67TCr 7.5TCr 3,20300Cr | EV / Sales 2026 * |
4.7x | EV / Sales 2027 * | 3.77x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab
| 1 day | -0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +55.20% | +4.14% | - | - | 1.74TCr | |
| +0.05% | +3.08% | +38.17% | +66.77% | 5.67TCr | |
| +0.50% | -6.01% | +23.49% | +62.11% | 5.2TCr | |
| +1.84% | +1.27% | -14.06% | -13.50% | 2.33TCr | |
| -0.15% | -6.00% | -9.42% | +344.47% | 2.13TCr | |
| +9.91% | -2.51% | +188.84% | +326.19% | 1.48TCr | |
| +3.83% | -1.34% | +47.77% | +165.22% | 1.38TCr | |
| +1.61% | +0.56% | +439.92% | +166.12% | 1.21TCr | |
| +3.14% | -12.56% | +59.51% | +149.39% | 1.11TCr | |
| -0.88% | -5.17% | +108.37% | +141.17% | 1.04TCr | |
| Average | +1.39% | -2.54% | +98.07% | +156.44% | 2.4TCr | |
| Weighted average by Cap. | +0.76% | -1.99% | +62.27% | +121.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.82TCr 434.71Cr 377.81Cr 352.72Cr 323.81Cr 610.56Cr 41TCr 621.2Cr 4.16TCr 1.63TCr 21TCr 1.63TCr 1.6TCr 68TCr | 3.32TCr 510.59Cr 443.76Cr 414.3Cr 380.33Cr 717.14Cr 49TCr 729.64Cr 4.89TCr 1.91TCr 24TCr 1.92TCr 1.88TCr 80TCr |
| Net income | 481.52Cr 74Cr 64Cr 60Cr 55Cr 104.08Cr 7.06TCr 105.9Cr 709Cr 277.68Cr 3.52TCr 278.35Cr 272.19Cr 12TCr | 705.4Cr 108.56Cr 94Cr 88Cr 81Cr 152.48Cr 10TCr 155.13Cr 1.04TCr 406.79Cr 5.16TCr 407.77Cr 398.74Cr 17TCr |
| Net Debt | 1.94TCr 298.59Cr 259.5Cr 242.27Cr 222.41Cr 419.37Cr 28TCr 426.68Cr 2.86TCr 1.12TCr 14TCr 1.12TCr 1.1TCr 47TCr | 1.18TCr 181.89Cr 158.08Cr 147.58Cr 135.48Cr 255.46Cr 17TCr 259.91Cr 1.74TCr 681.54Cr 8.65TCr 683.2Cr 668.07Cr 29TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
